Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in ANIX — Anixa Biosciences Inc

CIK 1390777 NEW YORK, NY
Back to ANIX Full portfolio

Position in ANIX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$132,836
+$10,437 QoQ
Shares Held
47,442
0.0% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 62 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. ANIX ranks #286 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in ANIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $132,836 47,442
2026-03-31 $122,399 47,442
2025-12-31 $181,805 58,271
2025-09-30 $192,294 58,271
2025-06-30 $192,294 58,271
2025-03-31 $168,009 58,745
2024-12-31 $136,289 58,746
2024-09-30 $185,045 58,745
2024-06-30 $161,439 73,050
2024-03-31 $271,595 87,050
2023-12-31 $375,016 96,654
2023-09-30 $315,871 96,597
2023-06-30 $311,686 97,402
2023-03-31 $419,757 97,618
2022-12-31 $414,876 97,618
2022-09-30 $481,451 97,856
2022-06-30 $299,439 97,856
2022-03-31 $270,306 98,652
2021-12-31 $292,995 98,652
2021-09-30 $470,569 98,652
2021-06-30 $168,011 43,302
2021-03-31 $238,408 50,942
2020-12-31 $159,544 51,969
2020-09-30 $95,695 39,381
2020-06-30 $120,505 39,381
2020-03-31 $62,615 39,381